IL154302A0 - Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine - Google Patents
Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetineInfo
- Publication number
- IL154302A0 IL154302A0 IL15430201A IL15430201A IL154302A0 IL 154302 A0 IL154302 A0 IL 154302A0 IL 15430201 A IL15430201 A IL 15430201A IL 15430201 A IL15430201 A IL 15430201A IL 154302 A0 IL154302 A0 IL 154302A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydropyridine
- paroxetine
- fluorophenyl
- hydroxymethyl
- benzyl
- Prior art date
Links
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
- STCJUTRPNGTJGE-UHFFFAOYSA-N [1-benzyl-4-(4-fluorophenyl)-3,6-dihydro-2h-pyridin-3-yl]methanol Chemical compound C1C=C(C=2C=CC(F)=CC=2)C(CO)CN1CC1=CC=CC=C1 STCJUTRPNGTJGE-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960002296 paroxetine Drugs 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006340 racemization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0021147.4A GB0021147D0 (en) | 2000-08-30 | 2000-08-30 | Chemical process |
| PCT/EP2001/009998 WO2002018338A1 (en) | 2000-08-30 | 2001-08-30 | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL154302A0 true IL154302A0 (en) | 2003-09-17 |
Family
ID=9898420
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15430201A IL154302A0 (en) | 2000-08-30 | 2001-08-30 | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| IL154302A IL154302A (en) | 2000-08-30 | 2003-02-05 | Process for the racemisation of 1 - benzyl- 4 - (4 - fluorophenyl) - 3 - hydroxymethyl - 1,2,3,6 - tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL154302A IL154302A (en) | 2000-08-30 | 2003-02-05 | Process for the racemisation of 1 - benzyl- 4 - (4 - fluorophenyl) - 3 - hydroxymethyl - 1,2,3,6 - tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6949650B2 (enExample) |
| EP (1) | EP1315701B1 (enExample) |
| JP (1) | JP2004518620A (enExample) |
| AT (1) | ATE421953T1 (enExample) |
| AU (1) | AU2002213865A1 (enExample) |
| CA (1) | CA2420579C (enExample) |
| CZ (1) | CZ2003503A3 (enExample) |
| DE (1) | DE60137577D1 (enExample) |
| ES (1) | ES2320631T3 (enExample) |
| GB (1) | GB0021147D0 (enExample) |
| HR (1) | HRP20030227A2 (enExample) |
| HU (1) | HUP0302910A3 (enExample) |
| IL (2) | IL154302A0 (enExample) |
| NO (1) | NO324944B1 (enExample) |
| SK (1) | SK2342003A3 (enExample) |
| WO (1) | WO2002018338A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2748140A (en) * | 1954-10-07 | 1956-05-29 | Rohm & Haas | 3-hydroxymethyl-4-phenyltetrahydro-pyridines and their esters |
| GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| BR9608471A (pt) * | 1995-05-17 | 1998-12-29 | Novo Nordisk As | Processo para a preparação de um composto |
| GB9526645D0 (en) * | 1995-12-28 | 1996-02-28 | Chiroscience Ltd | Stereoselective synthesis |
| HU221921B1 (hu) | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| GB9710004D0 (en) | 1997-05-17 | 1997-07-09 | Knoll Ag | Chemical process |
| DE19900576A1 (de) * | 1999-01-09 | 2000-07-13 | Merck Patent Gmbh | Benzolderivate |
-
2000
- 2000-08-30 GB GBGB0021147.4A patent/GB0021147D0/en not_active Ceased
-
2001
- 2001-08-30 AU AU2002213865A patent/AU2002213865A1/en not_active Abandoned
- 2001-08-30 US US10/362,531 patent/US6949650B2/en not_active Expired - Fee Related
- 2001-08-30 IL IL15430201A patent/IL154302A0/xx unknown
- 2001-08-30 HU HU0302910A patent/HUP0302910A3/hu unknown
- 2001-08-30 ES ES01982224T patent/ES2320631T3/es not_active Expired - Lifetime
- 2001-08-30 JP JP2002523456A patent/JP2004518620A/ja not_active Ceased
- 2001-08-30 EP EP01982224A patent/EP1315701B1/en not_active Expired - Lifetime
- 2001-08-30 CZ CZ2003503A patent/CZ2003503A3/cs unknown
- 2001-08-30 SK SK234-2003A patent/SK2342003A3/sk unknown
- 2001-08-30 WO PCT/EP2001/009998 patent/WO2002018338A1/en not_active Ceased
- 2001-08-30 CA CA002420579A patent/CA2420579C/en not_active Expired - Fee Related
- 2001-08-30 DE DE60137577T patent/DE60137577D1/de not_active Expired - Lifetime
- 2001-08-30 AT AT01982224T patent/ATE421953T1/de not_active IP Right Cessation
- 2001-08-30 HR HR20030227A patent/HRP20030227A2/xx not_active Application Discontinuation
-
2003
- 2003-02-05 IL IL154302A patent/IL154302A/en not_active IP Right Cessation
- 2003-02-25 NO NO20030876A patent/NO324944B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB0021147D0 (en) | 2000-10-11 |
| NO324944B1 (no) | 2008-01-07 |
| ES2320631T3 (es) | 2009-05-27 |
| IL154302A (en) | 2008-11-03 |
| US20040014786A1 (en) | 2004-01-22 |
| EP1315701B1 (en) | 2009-01-28 |
| HRP20030227A2 (en) | 2005-02-28 |
| ATE421953T1 (de) | 2009-02-15 |
| SK2342003A3 (en) | 2003-09-11 |
| CA2420579C (en) | 2009-11-03 |
| NO20030876D0 (no) | 2003-02-25 |
| CZ2003503A3 (cs) | 2003-08-13 |
| EP1315701A1 (en) | 2003-06-04 |
| HUP0302910A3 (en) | 2008-02-28 |
| WO2002018338A1 (en) | 2002-03-07 |
| HUP0302910A2 (hu) | 2004-01-28 |
| US6949650B2 (en) | 2005-09-27 |
| JP2004518620A (ja) | 2004-06-24 |
| AU2002213865A1 (en) | 2002-03-13 |
| CA2420579A1 (en) | 2002-03-07 |
| DE60137577D1 (de) | 2009-03-19 |
| NO20030876L (no) | 2003-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY111616A (en) | Nover (r)-5-carbamoyl-8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1-benzopyrans | |
| LU90999I2 (fr) | Escitalopram et ses sels pharmaceutiquement acceptables (cipralex) | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| YU9802A (sh) | Inhibitori ćelijske adhezije | |
| MX9806209A (es) | Proceso para la preparacion de d-treo-(r,r)-metil fenidato y recirculacion de enantiomeros no deseados a traves de epimerizacion. | |
| HU9802586D0 (en) | Racemizing process | |
| AU2003271811A8 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
| MXPA03010960A (es) | Proceso para la produccion de fexofenadina derivado de piperidina. | |
| AU2002220918A1 (en) | Process for preparing isomers of salbutamol | |
| YU10402A (sh) | Supstituisani 3-fenil-5-alkoksi-1,3,4-oksidiazol-2-oni i njihova upotreba za proizvodnju leka | |
| HRP20030227A2 (en) | Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine | |
| GR3017348T3 (en) | Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. | |
| MX9708612A (es) | Derivados de alfa-(alquilfenilo sustituido)-4-(hidroxidifenilmetil)-1-piperidinbutanol, su preparacion y su uso como antihistaminas, agentes antialergicos, y broncodilatadores. | |
| CA2320756A1 (en) | Process for the production of optically enriched (r)- or (s)-albuterol | |
| MXPA03006057A (es) | Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil. | |
| BG104073A (en) | Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds | |
| AU2002311623A1 (en) | Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents | |
| BR0008586A (pt) | Processo de preparação de aminoácidos quirais e processo de preparação de compostos a partir destes | |
| GEP20084296B (en) | Novel 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same | |
| AU2002212241A1 (en) | Method for producing chiral compounds | |
| AU2002210537A1 (en) | (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists | |
| MY112938A (en) | New highly selective process for the preparation of enantiomerically pure phenyl-substituted 1, 4- dihydropyridine-3,5-dicarboxylic acid derivatives | |
| MXPA05007528A (es) | Procedimiento de preparacion de (1s, 4r) 1-acetoxi-4-hidroxiciclopent-2-eno enriquecido enantiomericamente. |